Parkinson's Disease/Movement Disorders News

In this edition, foslevodopa-foscarbidopa improves motor symptoms in advanced PD, posterior surgery for treating cervical radiculopathy, Tysabri favored over IV in patients with relapsing-remitting MS and more.

Bromocriptine, a drug previously used to treat adults with type 2 diabetes and Parkinson’s disease, improved BP and central and peripheral aortic stiffness over 4 weeks in adolescents with type 1 diabetes, researchers reported.

The Parkinson’s Foundation and data analytics platform Tag.bio have announced a partnership to advance research into the causes and treatment of Parkinson’s disease.

In this edition, risk factors linked to PD, digital brain health platform offers dementia risk assessment, Klotho protein levels linked to Alzheimer's and more.

Biotechnology company Cajal Neuroscience announced its launch with $96 million Series A financing with plans to combine human genetics, functional genomics and advanced microscopy to expand drug discovery for neurodegenerative diseases.

The Feinstein Institutes for Medical Research has been awarded a $3.6 million grant, to be distributed over 5 years, from the New York State Department of Health for the study of spinal cord simulation and novel brain implant technology.

An increased risk for Parkinson’s disease was associated with a range of factors, comorbidities and prodromal features, some of which may appear 5 to 10 years prior to diagnosis, according to a study in JAMA Neurology.

Continuous subcutaneous foslevodopa-foscarbidopa improved motor symptoms and reduced motor fluctuations compared with oral levodopa-carbidopa in patients with advanced Parkinson’s disease, according to a study in The Lancet Neurology.

In this edition, neurologic effects of COVID-19 among pediatric populations, FDA accepts NDA for extended-release carbidopa/levodopa, antihistamines could be promising therapy for Parkinson’s disease and more.

Neurocrine Biosciences Inc. recently presented data on comorbidities, polypharmacy and treatment patterns of patients prescribed benztropine who also were being treated with antipsychotic medications.